Africa HepatoPancreatoBiliary Cancer Consortium

2026 AHPBCC Annual Conference

August 12–16, 2026 · Abuja, Nigeria

Collaborating to Improve HPB Cancer Control in Africa: Prevention, Treatment, Research, and Survivorship

About Us

In 2020, the Africa HepatoPancreatoBiliary Cancer Consortium (AHPBCC) was organized to harness resources and expertise across the African Continent, the United States, and Europe to investigate the influences of lifestyle, environment, viral and host biological factors on the development of HPB cancers. Today the Consortium has more than 200 clinicians and research investigators who inform new strategies for risk prevention, early detection, and improved survival of patients with these cancers.

Our Mission

Z

Develop and support collaborations between member groups

Z

Identify factors that influence the epidemiology, etiology, pathobiology, and prognosis of liver, biliary tract and pancreatic cancers

Z
Encourage free exchange of results (published or unpublished) and ideas in a collegial environment without fear of competition.

Objectives

Expand knowledge of the epidemiology, etiology, pathobiology and prognosis of liver, biliary tract and pancreatic cancers through:

Foster Collaborations

between clinicians and researchers in different countries;

Providing a forum

Providing a forum and framework for discussion, development and pursuit of new research directions and clinical care initiatives

Promote and support

high-quality patient and population-based basic and translational science research throughout Africa;

Supporting

Supporting the development and mentorship of early career researchers and clinicians.